ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Voice over time: long-term effects of therapy in muscle tension dysphonia with a 24-month follow-up.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMuscle tension dysphonia (MTD) is the most common functional voice disorder worldwide, yet evidence on the long-term effectiveness of voice therapy remains scarce. This study aimed to evaluate the sustainability of therapeutic outcomes in patients with MTD over a treatment-free period of at least 24 months.
methodsFifty-five participants were included: 25 patients with MTD and 30 healthy controls. All patients with MTD underwent an eight-week structured voice therapy program consisting of vocal hygiene education, relaxation techniques, resonant voice therapy, and laryngeal manual therapy. Assessments included videolaryngoscopic examination, acoustic analysis (F0, jitter, shimmer, NHR, VTI, SPI), and self-reported measures (Voice Handicap Index-10, Vocal Tract Discomfort Scale). Evaluations were conducted pre-therapy, post-therapy, and at least 24 months after treatment completion. Statistical analyses were performed using independent samples t-tests, Mann-Whitney U, Wilcoxon signed ranks, and chi-square tests.
resultsAt baseline, patients with MTD reported significantly higher VHI and VTDS scores compared to controls (p < 0.001), although acoustic parameters showed no significant differences. Following therapy, significant improvements were observed in jitter, shimmer, NHR, VTI, and all self-reported outcomes (p < 0.05). At the 24-month follow-up, most therapeutic gains were maintained, with no significant deterioration in acoustic parameters and sustained reductions in VHI and VTDS scores compared to baseline (p < 0.001). A subgroup of seven patients demonstrated resistance to therapy, with limited improvement in both early and long-term follow-up.
conclusionVoice therapy yields significant and durable improvements in both acoustic and self-reported outcomes in MTD, with benefits sustained for at least 24 months after treatment. Early recognition of resistant cases is critical, as these individuals may require booster sessions or adjunctive therapeutic approaches.
Indexed as
Identifiers
42165878What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.